Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

A new report from AARP Public Policy Institute found that the top 25 drugs prescribed under Medicare Part D have nearly ...

People with Medicare Part D plans shoulder a share of the cost of their prescription drugs. Under the standard Part D benefit ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

Concurrently, a preprint from the industry-backed Vital Transformation found a 50% drop in company investments into ...

Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, ...

Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...

AARP is a well-known company that offers supplemental health insurance for senior citizens looking to fill gaps in their Medicare coverage. The company offers eight Medicare plans through United ...

There’s a major change in 2025 to Medicare’s prescription drug coverage. This year, there’s a new $2,000 cap on annual out-of ...

Virginia AARP officials are ramping up a push for nursing home reform that includes a crucial certified nursing assistant ...

The first issue of AARP Bulletin in 2025 examines the physician shortage crisis and what it means for older adults. Additionally, this month’s issue provides insights on how to handle data breaches, ...